Ysabel Duron.

Who We Are at The Latino Cancer Institute

FOUNDER/EXECUTIVE DIRECTOR

Ysabel Duron.

Journalist, Cancer Survivor, Patient Advocate

FOUNDER/EXECUTIVE DIRECTOR
The Latino Cancer Institute
San Jose, CA

Ysabel Duron is a pioneering, award-winning Latina journalist, a cancer survivor, and for the last 23 years, a leading patient activist around Latino community engagement. Her encore career as a cancer patient advocate and non-profit agency builder commenced when she was diagnosed with cancer in 1999.

This past February President Joe Biden appointed Duron to the National Cancer Advisory Board which advises the Director of the National Cancer Institute. She is the first patient advocate to serve on the NCAB.

Duron describes her “work in and with community,” as a learning classroom and credits the experience with preparing her for her advocacy role. Among other things, her former agency developed programs for low income, Spanish-speaking and immigrant communities to address gaps along the cancer continuum including cancer awareness education, navigation into screening, psychosocial support groups and a lay community navigator program to support and guide low income, Spanish-speaking cancer patients in the public health care system in Santa Clara County (San Jose), California.

Between 2008 and 2016, under her leadership at Latinas Contra Cancer (LCC), Duron  convened 5 unique National Latino Cancer Summits, turning its lens on cancer issues in the Latino community, collaborating with advocacy groups, researchers and health care providers to investigate, and address cancer related impacts.

LCC also created linguistically and culturally appropriate education tools using a bingo game model to dispel myth and misinformation, promote healthy eating and exercise as well as screening and early detection; training up to 200 promotores aka community health workers to use these tools to raise awareness and navigate eligible participants into screenings.  This bingo concept was adapted for the African American and Pacific Islander communities, and cited by the NIEHS – IBCERCC Committee, on which Duron served, in the 2012 Breast Cancer and the Environment, Prioritizing Prevention Report.

In 2017, Ms. Duron launched her third and current agency, The Latino Cancer Institute (TLCI), to amplify Latino voices about the cancer burden – acting as a force multiplier through a nationwide network of stakeholders; dedicated to promote the work of Latino community service agencies; to provide collaboration with the global cancer research community; and to drive policy to improve health outcomes and diminish disproportionate Latino cancer mortality.

The Institute has since convened 4 National TLCI virtual Forums as Duron continues to bring together researchers, clinicians, advocates, government and industry officials across the cancer landscape.

TLCI’s collaborations include engagements with academic partners such as the Stanford Cancer Institute, Universities of California at San Francisco and Davis, Georgetown University Lombardi Comprehensive Cancer Center, George Washington Cancer Center, the California Primary Care Association (FQHCs), San Diego and San Jose State Universities. Duron is a published co-author in over 10 research papers.

TLCI’s robust engagement has resulted in two invitations to the White House, once for a re-launch (Feb 2022) of President Joe Biden’s Cancer Moonshot initiative to drive cancer screenings and decrease cancer mortality by 50% in 25 years. The 2nd White House event (Oct 2022) spotlighted the American Cancer Society launch of the newly formed National Breast Cancer Roundtable (NBCRT) on which Duron was invited to serve. NBCRT aims, among other policy initiatives, to address disparities in cancer screening and access, advanced diagnostics and quality treatment impacting racial and ethnic populations.

Duron also serves on the Institutional Review Board (IRB) of the All of Us Research Program at the National Institutes of Health; invited to join in 2016 by former NIH Director Francis Collins, as a patient advocate. 

Duron is also a member of the California Initiative to Advance Precision Medicine Advisory Council (CIAPM), which advises the Governor on the direction of Precision Medicine issues in the state.

As a member of the Independent Citizen’s Oversight Committee (since 2019) of the California Institute for Regenerative Medicine (CIRM), a tax-payer funded stem cell research program, Duron successfully drove a motion that requires research proposals to include a plan on recruiting a proportionate number of racial and ethnic minorities into newly funded COVID Clinical Trials. The expansion of diversity, equity and inclusion (DEI) has since been incorporated into the majority of Requests for Proposals funded by the Institute and drives frameworks for internal organizational operations. CIRM CEO, Maria Millan, said that the “culture,” has changed amongst CIRM scientific reviewers who now more vigorously question the quality of the DEI plan in the research proposals, which are also scored by patient advocates and can be returned to applicants for improvements.  

As a member of the National Rapid Research Coalition, for the Johns Hopkins University Center for Health Security between 2020 and 2022, Duron advised on the community’s role in an equitable and effective Covid vaccination rollout (titled CommuniVax), supported the research site team in California (one of five sites around the country), consulted on and assisted in editing the three CommuniVax national reports.

Duron was also elected in 2021 to the University of California Center for Data Drive Insights and Innovation (UCCDI2) which engages in a collaborative approach with UC Health to build a pre-eminent data-driven learning healthcare system that improves the human condition.

A broadcast journalist for 43 years, Duron was inducted into the National Association of Hispanic Journalists Hall of Fame in 2009. A 1970 graduate of San Jose State University with a B.A. in Journalism, Duron distinguished herself in both the journalism and non-profit worlds winning a number of prestigious awards. These include two Emmys, a Radio-TV News Director Award, the Girl Scouts Juliette Gordon Award for her Trouble with Teacher Series, the Silicon Valley NAACP Chapter W.E.B. Dubois Award, as well as the Living Legacy Award from the Chicana- Latina Foundation, the 2005 Bay Area Most Influential Latino from the SF Business Times, a Lifetime Achievement Award from the International Women’s Media Association, and the 2011 Latino Spirit Award from the Latino Caucus of the California Legislature.

Duron’s non-profit work garnered her the 150-thousand dollar Purpose Prize (2013) from ENCORE, and won her the Distinguished Public Service Award from the American Psychosocial Oncology Society among others.         

 

 

To reach Ysabel Duron: [email protected]

 

Yd/07/08/2023 /updated 


TLCI Blog by Ysabel Duron, President/Executive Director

08 Mar, 2024

Celebrate International Women’s Day: Equity in Healthcare

Celebrating International Women’s Day and A Women’s Right to Survive and Thrive

 

As I head to SXSW 2024 in Austin, one of the biggest gatherings of innovators, thought leaders, and world-class artists, this Friday I want to celebrate International Women’s Day by spotlighting the strength and resilience of women everywhere.  

 

I’ll be joining our host The City of Hope and Dr. Harlan Levine in conversation about Cancer Innovation and Those Who Are Left Behind.    The Latino Cancer Institute is a woman-built, mostly women-driven national non-profit dedicated to diminishing Latino cancer risk wherever we have the opportunity to make a difference. Our work to equalize access to quality cancer care for vulnerable populations, especially women and Latinas, is critical to our mission. 

 

Women are not only essential breadwinners and caregivers for their families, but they are also the critical backbone for the economic well-being of all countries. Yet, in many places, they continue to struggle for equal pay compared to their white male counterparts. 

 

Health is wealth, and if women are not in an economic position to afford their own healthcare and essential regular cancer screenings that lead to early intervention and better survival outcomes, then their families will also suffer should a beloved mother, sister, auntie or grandmother lose her life. 

Breast cancer is the leading cause of cancer incidence and death among Latinas in the U.S. They deserve equal and affordable access to advanced diagnostics, such as genetic and genomic testing, as well as quality early intervention and treatment, which can save lives and reduce costs.  

On this International Women’s Day, let’s not just celebrate women, but let’s also guarantee each and every one access to the tools and resources they need to survive, thrive, and make their mark wherever they live. #InspireInclusion  

 

(https://www.internationalwomensday.com/Missions/20202/What-does-it-mean-to-truly-inspire-inclusion) 

 

If you happen to be heading for SXSW, join us and we’ll keep the conversation going. 

 

Cancer Innovation and Those Who are Left Behind, SXSW 2024 

Mar 11, 2024, 4:00pm – 5:00pm CT 

https://schedule.sxsw.com/2024/events/PP141331 

06 Feb, 2024

TLCI 2023 Forum – Action Items & Policy

Thank you to those of you who attended The Latino Cancer Institute’s 5th Annual National Forum, The Turbulent Ecosystem: Climate Change and its Impact on the Latino Cancer Burden!
During the forum, we heard from distinguished researchers, policy-makers, clinicians, and advocates about the intersection between climate change and cancer, and specifically how it affects Latino communities. The presenters offered valuable action items that everyone can take to mitigate the negative health impacts of climate change. From businesses to governments, researchers to hospitals and clinics, community-based organizations, and community members themselves, we all have a role to play in protecting our most vulnerable populations from the toll that climate change is taking. Let’s work together to improve the health of our world, our communities, and ourselves.

16 Jan, 2024

Ysabel Duron on the MM+M Podcast at HLTH 2023

“If they’re not thinking that the Latino community is anything but poor immigrants running across the border, then they’re really losing out on a lucrative market.”

Support.

Help us help others

As a nonprofit organization, we rely on philanthropy and grants in our mission to support other agencies. Your funding allows us to continue the development of new programs and tools we can share with those making a difference in the lives of Latino cancer patients, survivors, and their caregivers.

Join our cause.
Únete a nuestra causa.